Journal
ACS NANO
Volume 17, Issue 21, Pages 21539-21552Publisher
AMER CHEMICAL SOC
DOI: 10.1021/acsnano.3c06551
Keywords
inflammatory boweldisease; silicon hydrogen nanoparticles; gut microbiota; reactive oxygen species; oraladministration
Ask authors/readers for more resources
This study developed silicon hydrogen nanoparticles with reactive oxygen species-scavenging ability for the treatment of inflammatory bowel diseases. The nanoparticles showed stability in gastric and intestinal fluids and efficiently cleared excess reactive oxygen species, protecting cells from oxidative stress-induced death. Through oral delivery, the nanoparticles targeted the inflamed colon and exhibited significant preventive and therapeutic effects.
The occurrence and development of inflammatory bowel diseases (IBDs) are inextricably linked to the excessive production of reactive oxygen species (ROS). Thus, there is an urgent need to develop innovative tactics to combat IBDs and scavenge excess ROS from affected areas. Herein, silicon hydrogen nanoparticles (SiH NPs) with ROS-scavenging ability were prepared by etching Si nanowires (NWs) with hydrogen fluoride (HF) to alleviate the symptoms associated with IBD by orally targeting the inflamed colonic sites. The strong reductive Si-H bonds showed excellent stability in the gastric and intestinal fluids, which exhibited efficient ROS-scavenging effects to protect cells from high oxidative stress-induced death. After oral delivery, the negatively charged SiH NPs were specifically adsorbed to the positively charged inflammatory epithelial tissues of the colon for an extended period via electrostatic interactions to prolong the colonic residence time. SiH NPs exhibited significant preventive and therapeutic effects in dextran sodium sulfate-induced prophylactic and therapeutic mouse models by inhibiting colonic shortening, reducing the secretion of pro-inflammatory cytokines, regulating macrophage polarization, and protecting the colonic barrier. As determined using 16S rDNA high-throughput sequencing, the oral administration of SiH NPs treatment led to changes in the abundance of the intestinal microbiome, which improved the bacterial diversity and restored the relative abundance of beneficial bacteria after the inflamed colon. Overall, our findings highlight the broad application of SiH-based anti-inflammatory drugs in the treatment of IBD and other inflammatory diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available